Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ·Healthcare·Biotechnology
$4.12
-3.06%
Mkt Cap $301.46M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.41 | -$0.49 | -19.51% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.49 | -$0.37 | +24.49% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$0.56 | -$0.37 | +33.93% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.67 | -$0.67 | +0.00% | — | — |
| Q1 2025 Mar 26, 2025 | — | $26.86M | — | -$0.75 | -$0.66 | +12.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.92 | -$0.56 | +39.13% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.83 | -$1.24 | -49.40% | — | — |
| Q2 2024 May 7, 2024 | $13.12M | $40.56M | +209.15% | -$0.77 | $0.14 | +118.18% | — | — |
| Q1 2024 Feb 27, 2024 | — | $2.10M | — | -$0.92 | -$0.83 | +9.78% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$1.01 | -$0.79 | +21.78% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$1.06 | -$1.85 | -74.53% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$0.96 | -$1.07 | -11.46% | — | — |
| Q1 2023 Mar 1, 2023 | — | — | — | -$1.09 | -$0.92 | +15.60% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$1.15 | -$0.96 | +16.52% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$1.21 | -$1.34 | -10.74% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$1.20 | -$1.31 | -9.17% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$1.34 | -$1.11 | +17.16% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$1.31 | -$0.09 | +93.13% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$1.14 | -$1.34 | -17.54% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$0.96 | -$1.24 | -29.17% | — | — |